Abstract
Serum opsonization of two organisms, E. coli and yeasts (S. cerivisiae), was examined in 68 patients with chronic liver disease (CLD). Impaired opsonization for yeasts was found in seven (29%) of 24 patients with chronic active hepatitis, six (27%) of 22 with alcoholic cirrhosis and five (23%) of 22 with primary biliary cirrhosis. Opsonization for E. coli was normal in patients with primary biliary cirrhosis but impaired in seven (29%) patients with chronic active hepatitis and three (14%) of those with alcoholic cirrhosis. The defect of opsonization in chronic active hepatitis was found mainly in patients with histological evidence of active disease. A deficiency, rather than antagonism or inhibition, of normal opsonization factors was responsible, but could not be related to reduced levels of serum complement factors of either the classical or the alternative pathway present in 45% of the patients with chronic active hepatitis, 71% with alcoholic cirrhosis and 18% of those with primary biliary cirrhosis. Serum from two of 11 patients with impaired opsonization antagonised the function of normal polymorphonuclear leucocytes, and polymorphonuclear leucocytes from six of seven patients had slightly reduced phagocytosis/killing of E. coli opsonized in normal serum. Defects of serum opsonization, complement activity and polymorphonuclear leucocyte function may be causes of the increased susceptibility to bacterial infection in patients with CLD.
MeSH Terms
Adolescent
Adult
Aged
Chronic Disease
Complement System Proteins/metabolism
Escherichia coli/immunology
Hepatitis/immunology
Humans
Immunoglobulins/metabolism
Liver Cirrhosis, Biliary/immunology
Liver Diseases/immunology
Liver Diseases, Alcoholic/immunology
Middle Aged
Neutrophils/immunology
Opsonin Proteins/immunology
Phagocytosis
Saccharomyces cerevisiae/immunology
Chemicals
Immunoglobulins
Opsonin Proteins
Complement System Proteins
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Wyke R J
Rajkovic I A
Williams R
References (12)
12 references, click to expand
-
In vitro bactericidal capacity of human polymorphonuclear leukocytes: diminished activity in chronic granulomatous disease of childhood.
J Clin Invest. 1967 Apr;46(4):668-79
PMID: 6021213
-
Bacteraemia in association with hepatocellular and hepatobiliary disease.
Postgrad Med J. 1967 Mar;43:Suppl 43:7-11
PMID: 6039925
-
Homozygous deficiency of C3 in a patient with repeated infections.
Lancet. 1972 Dec 2;2(7788):1179-81
PMID: 4117597
-
Phagocytosis as a surface phenomenon. II. Contact angles and phagocytosis of encapsulated bacteria before and after opsonization by specific antiserum and complement.
J Reticuloendothel Soc. 1972 Nov;12(5):497-502
PMID: 4120360
-
Complement and liver cell function in 53 patients with liver disease.
Am J Med. 1973 Dec;55(6):783-90
PMID: 4796289
-
Haemolytic diffusion plate assays for factors B and D of the alternative pathway of complement activation.
Immunochemistry. 1976 Apr;13(4):317-24
PMID: 820630
-
Suppression of leukocyte chemotaxis by human IgA myeloma components.
J Exp Med. 1976 Nov 2;144(5):1227-42
PMID: 825608
-
A defect of the alternative pathway of complement.
Clin Exp Immunol. 1977 Jan;27(1):30-3
PMID: 321158
-
Defective opsonisation and complement deficiency in serum from patients with fulminant hepatic failure.
Gut. 1980 Aug;21(8):643-9
PMID: 7000632
-
[Serum secretory IgA in liver diseases and various other disorders (author's transl)].
Gastroenterol Clin Biol. 1981 Mar;5(3):305-13
PMID: 7227737
-
Current view of neutrophil dysfunction: an integrated clinical perspective.
Am J Med. 1981 Jun;70(6):1237-6
PMID: 7015856
-
Neutrophil function in chronic liver disease.
Clin Exp Immunol. 1981 Jul;45(1):81-9
PMID: 7030541